Skip to search formSkip to main contentSkip to account menu

vaccine adjuvant

Known as: adjuvants vaccine 
A substance added to a vaccine to improve the immune response so that less vaccine is needed.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2020
Highly Cited
2020
Engineered immunogen binding to alum adjuvant enhances humoral immunity
Adjuvants are central to the efficacy of subunit vaccines. Aluminum hydroxide (alum) is the most commonly used vaccine adjuvant… 
Highly Cited
2017
Highly Cited
2017
A Powerful CD8+ T‐Cell Stimulating D‐Tetra‐Peptide Hydrogel as a Very Promising Vaccine Adjuvant
A novel vaccine adjuvant based on a supramolecular hydrogel of a D-tetra-peptide is reported. Antigens can be easily incorporated… 
Review
2011
Review
2011
Trends in vaccine adjuvants
Adjuvants are essential components of most clinically used vaccines. This is because the majority of nonliving vaccines are… 
Review
2011
Review
2011
Influenza virosomes as vaccine adjuvant and carrier system
The basic concept of virosomes is the controlled in vitro assembly of virus-like particles from purified components. The first… 
Review
2011
Review
2011
Carbohydrate-based immune adjuvants
The role for adjuvants in human vaccines has been a matter of vigorous scientific debate, with the field hindered by the fact… 
Highly Cited
2010
Highly Cited
2010
Design of a potent CD1d-binding NKT cell ligand as a vaccine adjuvant
The glycolipid α-galactosylceramide (α-GalCer) has been shown to bind CD1d molecules to activate invariant natural killer T (iNKT… 
Highly Cited
2010
Highly Cited
2010
Liposomes based on dimethyldioctadecylammonium promote a depot effect and enhance immunogenicity of soluble antigen.
Highly Cited
2006
Highly Cited
2006
Efficient Immunization and Cross-Priming by Vaccine Adjuvants Containing TLR3 or TLR9 Agonists Complexed to Cationic Liposomes1
Complexing TLR9 agonists such as plasmid DNA to cationic liposomes markedly potentiates their ability to activate innate immunity… 
Review
2000
Review
2000
Improving vaccine performance with adjuvants.
New vaccines are presently under development and in testing for the control of infectious diseases, including human… 
Highly Cited
1998
Highly Cited
1998
Dendritic cells internalize vaccine adjuvant after intramuscular injection.
Vaccine adjuvants help antigens elicit rapid, potent, and long-lasting immune responses. The lack of understanding of the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)